Inovio Pharmaceuticals, Inc. (INO)

$6.77 -0.15% $-0.01 Healthcare

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

$175.78M

Dr. Jacqueline E. Shea Ph.D.

317.00

Plymouth Meeting, PA

Dec 08, 1998

-1.34

$-5.07

1.30

4.45

-20,552.27%

-1.52

-0.49

1.91

297.43

4.45

-90.91%

-108.93%

Similar stocks (7)

Novavax, Inc.

NVAX

$12.56 -2.86%
Neutral

Vaxart, Inc.

VXRT

$0.90 -2.64%
Neutral

Elevation Oncology, Inc.

ELEV

$0.59 -1.54%
Downtrend

Ocean Biomedical, Inc.

OCEA

$0.98 -3.23%
Downtrend

Enveric Biosciences, Inc.

ENVB

$0.49 0.43%
Downtrend

Hepion Pharmaceuticals, Inc.

HEPA

$0.68 -0.88%
Downtrend

CohBar, Inc.

CWBR

$0.48 11.63%
Downtrend

ETF Exposure (29)

ETFMG Treatments, Testing and Advancements ETF

GERM

0.52%

$19.16 -0.29%
Uptrend

iShares Micro-Cap ETF

IWC

0.04422%

$123.83 0.30%
Uptrend

Vanguard Horizon Funds - Vanguard Strategic Equity Fund

VSEQX

0.02%

$39.15 0.13%
Uptrend

Vanguard Strategic Small-Cap Equity Fund Investor Shares

VSTCX

0.02%

$42.04 0.12%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.02%

$147.48 0.05%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.01283%

$167.32 0.13%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$88.74 0.03%
Uptrend

iShares Russell 2000 ETF

IWM

0.00672%

$219.45 0.02%
Uptrend

ProShares Ultra Russell2000

UWM

0.002445038109961857%

$42.29 -0.05%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

0.00167494%

$63.75 -0.08%
Uptrend

ProShares UltraPro Russell2000

URTY

0.001205131238314532%

$51.08 0.10%
Uptrend

ProShares Hedge Replication ETF

HDG

0.0010268314652181307%

$50.00 0.40%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

7.3625e-4%

$33.53 -0.24%
Uptrend

iShares Russell 3000 ETF

IWV

6.4e-4%

$320.03 -0.31%
Uptrend

Dimensional U.S. Equity ETF

DFUS

3.3432e-4%

$60.66 -0.26%
Uptrend

Dimensional US Core Equity Market ETF

DFAU

1.9385000000000002e-4%

$38.71 -0.18%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$68.60 0.03%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.43 -0.28%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.42 -0.28%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.42 -0.26%
Uptrend

Vanguard Health Care Index Fund

VHT

0%

$284.83 -0.19%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$136.02 0.03%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.13 -0.25%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.11 -0.25%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.99 -0.24%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$248.45 -0.40%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$277.35 -0.25%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.97 -0.24%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$179.34 0.03%
Uptrend